Since tracking began
$ICLR has been tracked since 2026-03-01. It was down 48.7% from its 52-week high then — now down -35.2%.
It has clawed back 19.5 percentage points off that level. It bottomed 54.0% below that high along the way.
Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
ICLR qualifies for the Amber List on decline depth.
The structural read
What price action says about ICLR.
ICLR qualifies for the Amber List on decline depth — down -35.2% from its rolling 252-day high.
Alongside that decline, our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames — moderate or strong time-frame-continuity (TFC) alignment — so the ticker also carries a Recovering badge. The two readings coexist: the tier tells you how deep the damage is, the Recovering badge tells you whether momentum may be turning. Recovering is not a buy signal; it's a structural read.
Broken Stocks stops here — it flags the structure, it doesn't build the upside case. Working out whether ICLR's turn is investable is what our sister tool does: ConvictionEdge — triple-engine conviction research on names showing a recovery signal.
Upstream TFC read: strong alignment, current phase daily. Last bar types — daily 2U (green), weekly 2U (green), monthly 2U (green).
52-week range
Sector context · Healthcare
194 other Healthcare tickers are on Broken Stocks.
Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →
Questions about ICLR
What people ask.
Why is ICLR on Broken Stocks?
ICLR qualifies for the Amber List on decline depth. It is down -35.2% from its rolling 252-day high of $211.00, set on 2025-07-24 — 308d ago. It additionally carries a Recovering badge — see below.
What does the Recovering badge mean for ICLR?
Recovering means our proprietary engine has flagged a confirmed bullish structural signal on one or more time frames (moderate or strong time-frame continuity). It coexists with the decline tier — ICLR is still Amber List because the rolling-252-day decline hasn't healed, but a bullish setup has formed inside that decline. The two readings answer different questions: the tier tells you how deep the damage is; the Recovering badge tells you whether momentum may be turning. It's not a buy recommendation.
Is ICLR a falling knife?
Not by the strict technical definition. ICLR is down -35.2% from its 52-week high, but that high was set 308d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. ICLR is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.
Is ICLR a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is ICLR trading inside its 52-week range?
At $136.80, ICLR sits 48.6% of the way from its 52-week low ($66.57) to its 52-week high ($211.00). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has ICLR been declining?
The current 35.2% decline accrued over 308d, which annualizes to roughly -41.7% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does ICLR compare to its sector?
There are 194 other Healthcare tickers on Broken Stocks: 89 Red, 46 Amber, 59 Watch, with 107 showing recovering structural signals. Median sector decline is -36.0% — ICLR's decline is shallower than the sector median.